142 related articles for article (PubMed ID: 19350124)
1. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
Jayo A; Arnold E; González-Manchón C; Green D; Lord ST
Thromb Haemost; 2009 Apr; 101(4):770-2. PubMed ID: 19350124
[No Abstract] [Full Text] [Related]
2. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk).
Lefebvre P; Velasco PT; Dear A; Lounes KC; Lord ST; Brennan SO; Green D; Lorand L
Blood; 2004 Apr; 103(7):2571-6. PubMed ID: 14615374
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
[No Abstract] [Full Text] [Related]
4. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Brennan SO; Davis RL
Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
[No Abstract] [Full Text] [Related]
5. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
6. Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
Brennan SO; Oliver J; Davis RL
Thromb Haemost; 2011 Feb; 105(2):379-81. PubMed ID: 21057694
[No Abstract] [Full Text] [Related]
7. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
Li Y; Ding B; Wang X; Ding Q
Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369
[TBL] [Abstract][Full Text] [Related]
8. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.
Homer VM; Mullin JL; Brennan SO; Barr A; George PM
J Thromb Haemost; 2003 Jun; 1(6):1245-50. PubMed ID: 12871326
[TBL] [Abstract][Full Text] [Related]
9. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B
Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372
[No Abstract] [Full Text] [Related]
10. Two novel mutations at contiguous codons in the fibrinogen Bbeta chain associated with hypofibrinogenaemia.
Davis RL; May S; Chunilal S; Brennan SO
Thromb Haemost; 2009 May; 101(5):980-2. PubMed ID: 19404555
[No Abstract] [Full Text] [Related]
11. A new heterozygous mutation in gamma fibrinogen gene leading to 326 Cys-->Ser substitution in fibrinogen Córdoba is associated with defective polymerization and familial hypodysfibrinogenemia.
Guglielmone HA; Sanchez MC; Abate Daga D; Bocco JL
J Thromb Haemost; 2004 Feb; 2(2):352-4. PubMed ID: 14996011
[No Abstract] [Full Text] [Related]
12. Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.
Rein CM; Anderson BL; Ballard MM; Domes CM; Johnston JM; Madsen RJ; Wolper KK; Terker AS; Strother JM; Deloughery TG; Farrell DH
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):494-7. PubMed ID: 20386430
[TBL] [Abstract][Full Text] [Related]
13. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
[TBL] [Abstract][Full Text] [Related]
14. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.
Ding Q; Yang L; Zhao X; Wu W; Wang X; Rezaie AR
Thromb Haemost; 2017 Feb; 117(3):479-490. PubMed ID: 27975099
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
[TBL] [Abstract][Full Text] [Related]
18. A novel fibrinogen gamma chain mutation (gamma 239 Gln-->His) is the cause of dysfibrinogenemia Vicenza.
Castaman G; Ghiotto R; Duga S; Rodeghiero F
J Thromb Haemost; 2005 Mar; 3(3):600-1. PubMed ID: 15748264
[No Abstract] [Full Text] [Related]
19. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
20. Extensive arterial thrombosis in a patient with factor V Leiden mutation.
Mandegar MH; Saidi B; Roshanali F
Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):127-9. PubMed ID: 20360208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
